FDA Drug recall D-0592-2024
Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1
- FDA Drug
- Class III
- ongoing
- Published 2024-07-17
On 2024-07-17 the FDA classified a Class III recall of Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1 by Zydus Pharmaceuticals Usa, citing cross contamination with other products.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0592-2024 |
| Classification | Class III |
| Status | ongoing |
| Initiated | 2024-07-02 |
| Published | 2024-07-17 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Zydus Pharmaceuticals Usa |
| Distribution | US |
Product
Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-7; (b) 5x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-5; Rx Only, Manufactured by: Zydus Lifesciences Ltd. Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA)Inc., Pennington, NJ 08534,
Reason
Cross contamination with other products.
Identifiers
| ndc | 70710-1643-5 |
|---|---|
| ndc | 70710-1643-7 |
| ndc | 70710-1644-1 |
| ndc | 70710-1644-5 |
| ndc | 70710-1643-1 |
| code_info | Lot# (a) Lots L300255, L300262, Exp Date 07/31/2025; (b)L300263, Exp Date 08/31/2025 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0592-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.